Credit Suisse AG lifted its stake in shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN – Get Rating) by 0.9% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 70,648 shares of the company’s stock after purchasing an additional 656 shares during the period. Credit Suisse AG’s holdings in Ryan Specialty were worth $2,870,000 at the end of the most recent quarter.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Royal Bank of Canada raised its stake in Ryan Specialty by 524.8% in the 1st quarter. Royal Bank of Canada now owns 781 shares of the company’s stock valued at $31,000 after acquiring an additional 656 shares during the period. American International Group Inc. bought a new stake in Ryan Specialty in the 2nd quarter valued at $50,000. Quantbot Technologies LP bought a new stake in Ryan Specialty in the 2nd quarter valued at $51,000. Tower Research Capital LLC TRC raised its stake in Ryan Specialty by 340.3% in the 3rd quarter. Tower Research Capital LLC TRC now owns 1,823 shares of the company’s stock valued at $74,000 after acquiring an additional 1,409 shares during the period. Finally, Counterpoint Mutual Funds LLC bought a new stake in Ryan Specialty in the 3rd quarter valued at $112,000. Institutional investors own 26.82% of the company’s stock.
Ryan Specialty Stock Performance
RYAN opened at $40.80 on Friday. The firm has a market cap of $10.59 billion, a P/E ratio of 80.00 and a beta of 0.48. Ryan Specialty Holdings, Inc. has a 52-week low of $32.13 and a 52-week high of $46.40. The company has a debt-to-equity ratio of 2.58, a quick ratio of 1.27 and a current ratio of 1.27. The business’s fifty day moving average is $42.25 and its 200-day moving average is $41.67.
Analysts Set New Price Targets
A number of research firms recently weighed in on RYAN. UBS Group dropped their price target on Ryan Specialty to $48.00 in a research note on Wednesday, November 16th. Barclays decreased their price objective on Ryan Specialty to $49.00 in a report on Wednesday, November 16th. Wells Fargo & Company upped their price objective on Ryan Specialty from $47.00 to $49.00 and gave the company an “overweight” rating in a report on Wednesday. Royal Bank of Canada decreased their price objective on Ryan Specialty from $47.00 to $46.00 and set a “sector perform” rating on the stock in a report on Friday, November 11th. Finally, Citigroup initiated coverage on Ryan Specialty in a report on Wednesday, December 14th. They issued a “neutral” rating and a $42.00 price objective on the stock. One analyst has rated the stock with a sell rating, two have issued a hold rating and three have assigned a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $46.38.
Ryan Specialty Profile
Ryan Specialty Group Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.
- Get a free copy of the StockNews.com research report on Ryan Specialty (RYAN)
- The 3 Most Upgraded Stocks Are Reversing
- How to Find Blue Chip Dividend Stocks
- Zscaler, Inc Plummets, Is It Time To Buy The Dip?
- What is a Good Dividend Yield? How to Decide
- Taiwan Semiconductor Manufacturing Expanding in the West
Want to see what other hedge funds are holding RYAN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ryan Specialty Holdings, Inc. (NYSE:RYAN – Get Rating).
Receive News & Ratings for Ryan Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryan Specialty and related companies with MarketBeat.com's FREE daily email newsletter.